Towards a first-in-human trial with a pseudotyped lentivirus

Towards a first-in-human trial with a pseudotyped lentivirus

Bibliografiset tiedot
Päätekijät:	Alton, EW, Boyd, A, Davies, JC, Gill, DR, Griesenbach, U, Harman, TE, Hyde, S, McLachlan, G
Aineistotyyppi:	Conference item
Kieli:	English
Julkaistu:	Wiley 2020

Samankaltaisia teoksia

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS IN A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY
Tekijä: Griesenbach, U, et al.
Julkaistu: (2012)

Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy.
Tekijä: Griesenbach, U, et al.
Julkaistu: (2012)

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS AS A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY
Tekijä: Griesenbach, U, et al.
Julkaistu: (2012)

Preparation for a first-in-man lentivirus trial in cystic fibrosis patients
Tekijä: Griesenbach, U, et al.
Julkaistu: (2016)

Gene therapy for respiratory diseases; progress and a changing context
Tekijä: Alton, EWFW, et al.
Julkaistu: (2020)

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.
Tekijä: Alton, E, et al.
Julkaistu: (2016)

Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients
Tekijä: Sergijenko, A, et al.
Julkaistu: (2020)

Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
Tekijä: Hyde, S, et al.
Julkaistu: (2015)

Lentivirus gene therapy for autoimmune pulmonary alveolar proteinosis
Tekijä: Palau, H, et al.
Julkaistu: (2019)

Lentivirus GM-CSF gene therapy for autoimmune pulmonary alveolar proteinosis
Tekijä: Lund-Palau, H, et al.
Julkaistu: (2018)

Lentivirus GM-CSF gene therapy ameliorates autoimmune pulmonary alveolar proteinosis
Tekijä: Lund-Palau, H, et al.
Julkaistu: (2018)

Discovery and analysis of the first endogenous lentivirus
Tekijä: Katzourakis, A, et al.
Julkaistu: (2007)

Discovery and analysis of the first endogenous lentivirus.
Tekijä: Katzourakis, A, et al.
Julkaistu: (2007)

TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL
Tekijä: Griesenbach, U, et al.
Julkaistu: (2011)

Moving lentiviral-based gene therapy into a first-in-man CF trial
Tekijä: Griesenbach, D, et al.
Julkaistu: (2015)

Vesicular stomatitis virus glycoprotein- and Venezuelan equine encephalitis virus-derived glycoprotein-pseudotyped lentivirus vectors differentially transduce corneal endothelium, trabecular meshwork, and human photoreceptors.
Tekijä: Lipinski, D, et al.
Julkaistu: (2014)

A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution.
Tekijä: Gifford, R, et al.
Julkaistu: (2008)

Use of pseudotyped, replication deficient influenza to facilitate testing of gene delivery strategies for treatment of highly infectious diseases
Tekijä: Tan, T, et al.
Julkaistu: (2018)

LONGITUDINAL ASSESSMENT OF BIOMARKERS FOR CLINICAL TRIALS OF NOVEL THERAPEUTIC AGENTS: THE RUN-IN STUDY
Tekijä: Alton, E, et al.
Julkaistu: (2010)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis
Tekijä: Alton, E, et al.
Julkaistu: (2013)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis.
Tekijä: Alton, E, et al.
Julkaistu: (2013)

Recombinant Sendai virus vector to evaluate vector distribution in a large animal model of lung gene transfer
Tekijä: McLachlan, G, et al.
Julkaistu: (2004)

A PHASE 2B DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF NON-VIRAL MEDIATED GENE THERAPY FOR CF
Tekijä: Alton, E, et al.
Julkaistu: (2013)

Single cell assays for quantifying MRNA and protein during cystic fibrosis gene therapy trials
Tekijä: Sinadinos, A, et al.
Julkaistu: (2020)

REPEAT ADMINISTRATION OF GL67A/PGM169 IS FEASIBLE, SAFE, AND PRODUCES ENDOGENOUS LEVELS OF CFTR EXPRESSION AFTER 12 DOSES
Tekijä: Alton, E, et al.
Julkaistu: (2012)

Cumulative CFTR expression following repeated aerosol delivery of non-viral pGM169/GL67A formulation to mouse lung
Tekijä: Alton, E, et al.
Julkaistu: (2012)

Update on the UK CF Gene Therapy Consortium Multidoes, non-viral, gene therapy trial
Tekijä: Alton, E, et al.
Julkaistu: (2012)

LONGITUDINAL ASSESSMENT OF BIOMARKERS FOR CLINICAL TRIALS OF NOVEL THERAPEUTIC AGENTS; THE RUN-IN STUDY
Tekijä: Alton, E, et al.
Julkaistu: (2010)

Recombinant Sendai virus vector to evaluate vector distribution in a large animal model of lung gene transfer
Tekijä: McLachlan, G, et al.
Julkaistu: (2004)

Insertional mutagenesis in zebrafish using a pseudotyped retroviral vector
Tekijä: Gaiano, Nicholas R. (Nicholas Roger)
Julkaistu: (2008)

OPTIMISATION OF MOLECULAR ASSAYS FOR CLINICAL TRIAL OF GL67A/PDNA DELIVERY TO NOSE AND LUNG OF CF PATIENTS
Tekijä: Sumner-Jones, S, et al.
Julkaistu: (2009)

Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunity.
Tekijä: Powell, T, et al.
Julkaistu: (2012)

Investigating pseudotyped lentiviral vectors for gene delivery to the lung
Tekijä: Munday, RJ
Julkaistu: (2021)

UPDATE ON THE UK CF GENE THERAPY CONSORTIUM MULTIDOSE, NON-VIRAL, GENE THERAPY TRIAL
Tekijä: Alton, E, et al.
Julkaistu: (2012)

UPDATE ON THE UK CF GENE THERAPY CONSORTIUM MULTIDOSE, NON-VIRAL, GENE THERAPY TRIAL
Tekijä: Alton, E, et al.
Julkaistu: (2012)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
Tekijä: Alton, E, et al.
Julkaistu: (2014)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung
Tekijä: Alton, E, et al.
Julkaistu: (2014)

Lentiviral vector pseudotyped with sendai virus F and HN proteins uses sialylated glycan receptors to efficiently target human airway cells
Tekijä: Munday, RJ, et al.
Julkaistu: (2020)

F/HN pseudotyped lentiviral vector uses alpha 2,3 sialylated N-acetyllactosamine to efficiently transduce human airway cells
Tekijä: Munday, RJ, et al.
Julkaistu: (2022)

Use of a pseudotyped retoviral vector to accomplish insertional mutagenesis in zebrafish
Tekijä: Amsterdam, Adam (Adam Henry), 1967-
Julkaistu: (2009)